Award
National Cancer Institute 11306032
Bromodomain and extra-terminal motif (BET) inhibitors in Solitary fibrous tumor (SFT)
Recipient
University of Texas Dallas
Award Amount
$399,996.00
Ceiling
$399,996.00
Awarded
April 27, 2026
Identifier
11306032
Award for research on BET inhibitors targeting Solitary fibrous tumors to explore molecular mechanisms and assess clinical trial potential.
Description
The project involves evaluating BET inhibitors against Solitary fibrous tumors, exploring molecular mechanisms, and assessing safety and efficacy for potential clinical trials.